Endo Axiom
PrivateLast Round
Grant
Jun 30, 2025
Total Funding Raised
$2.22M
Company Overview
Endo Axiom operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Grant round in June 2025.
Endo Axiom is a biotechnology company developing platforms for the oral delivery of drugs and biologics, including an oral smart insulin and an immune modulation platform to prevent type one diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endo Axiom Comparables
Compare Endo Axiom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fortive Corporation | 79% | |
| NewCura | 78% | |
| EnvisionNEXT | 77% |
For institutional investors. Book with your work email.
Endo Axiom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 30, 2025 | ||||
| Seed | Apr 18, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Endo Axiom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Proto Axiom | Seed |
| MTPConnect | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 106% MoM, reaching 2.4K.
- May 16, 2026
Monthly visitors increased 151% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 11, 2026
In 2024, Endo Axiom Pty Ltd. partners with Abinitio under a manufacturing agreement to produce oral insulin for the clinical trial.
For institutional investors. Book with your work email.
Endo Axiom Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Endo Axiom's valuation, stock price, and market status.
Is Endo Axiom a public or private company?
Endo Axiom is a private company.
What is the current stock price of Endo Axiom?
Endo Axiom is a private company, so its shares have no public market price. Caplight tracks Endo Axiom's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Endo Axiom worth (valuation)?
Valuation information for Endo Axiom is not publicly available.
Can I buy Endo Axiom stock?
Endo Axiom shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Endo Axiom's last funding round?
Endo Axiom's most recent funding round was Grant on June 30, 2025.
Who are the main investors in Endo Axiom?
Key investors in Endo Axiom include Proto Axiom.
Will Endo Axiom IPO soon?
No public IPO plans have been announced for Endo Axiom.
How can I track Endo Axiom secondary market activity?
Caplight tracks bids, offers, and trades in Endo Axiom's shares on secondary markets.